A National Point Prevalence Study on Healthcare-associated Infections and Antimicrobial Use in Austria

Overview

Journal Wien Klin Wochenschr

Publisher Springer

Specialty General Medicine

Date 2016 Jan 29

PMID 26817781

Citations 9

Authors

Luigi Segagni Lusignani

Alexander Blacky

Peter Starzengruber

Magda Diab-Elschahawi

Thomas Wrba

Elisabeth Presterl

Affiliations

Soon will be listed here.

Abstract

Background: The first point prevalence survey performed in Austria had the aim to assess the magnitude of healthcare-associated infections and antimicrobials use in the country.

Methods: A multicentre study was carried out from May until June 2012 in nine acute care hospitals with a mean bed number of 620. Data from 4321 patients' clinical charts were reviewed.

Results: The overall healthcare-associated infections prevalence was 6.2% (268/4321) with the highest rate in intensive care departments (20.9%; 49/234). In medical and surgical departments the healthcare-associated infections prevalence was 5.4% (95/1745) and 6.6% (105/1586), respectively. The most frequent healthcare-associated infections were: urinary tract infections (21.3%; 61/287), pneumonia (20.6%; 59/287) and surgical site infections (17.4%; 50/287). The most common isolated microorganisms were: Escherichia coli (14.8%; 26/176), Enterococcus species (13.1%; 23/176) and Pseudomonas aeruginosa (11.4%; 20/176). Thirty-three per cent (1425/4321) of the patients received antimicrobials because of community-acquired infections treatment (14.2%; 615/4321), healthcare-associated infections treatment (6.4%; 278/4321), and surgical (8.2%; 354/4321) and medical prophylaxis (3.2%; 138/4321). Surgical prophylaxis was the indication for 22.0% (394/1792) of the overall prescriptions and was prolonged for more than 1 day in 77.2% (304/394) of the cases.

Conclusion: The national Austrian survey proved the feasibility of a nation-wide network of surveillance of both healthcare-associated infections and antimicrobial use that will be repeated in the future. Healthcare-associated infections and antimicrobial use have been confirmed to be a grave health problem. The excessive prolongation of perioperative prophylaxis in Austria needs to be limited.

Citing Articles

[Health Technology Assessment of the Probiotic Cleaning Hygiene System (PCHS)].

Calabro G, Caselli E, Rognoni C, Laurenti P, Moscato U, DI Pietro M J Prev Med Hyg. 2023; 63(3 Suppl 1):E1-E123.

PMID: 36819908 PMC: 9910312. DOI: 10.15167/2421-4248/jpmh2022.63.3s1.

Predicting Healthcare-associated Infections: are Point of Prevalence Surveys data useful?.

Golfera M, Toscano F, Cevenini G, DE Marco M, Porchia B, Serafini A J Prev Med Hyg. 2022; 63(2):E304-E309.

PMID: 35968075 PMC: 9351422. DOI: 10.15167/2421-4248/jpmh2022.63.2.1496.

Point-prevalence surveys of antimicrobial consumption and resistance at a paediatric and an adult tertiary referral hospital in Yangon, Myanmar.

Oo W, Carr S, Marchello C, San M, Oo A, Oo K Infect Prev Pract. 2022; 4(1):100197.

PMID: 35005602 PMC: 8717234. DOI: 10.1016/j.infpip.2021.100197.

Use of monitoring indicators in hospital management of antimicrobials.

da Silva R, de Mendonca S, Leao I, Nery Dos Santos Q, Batista A, Melo M BMC Infect Dis. 2021; 21(1):827.

PMID: 34404348 PMC: 8369325. DOI: 10.1186/s12879-021-06542-5.

Atti Le giornate della ricerca scientificae delle esperienze professionali dei giovani: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI) Roma 20-21 dicembre 2019.

J Prev Med Hyg. 2020; 60(4 Suppl 3):E1-E85.

PMID: 32258536 PMC: 7105054. DOI: 10.15167/2421-4248/jpmh2019.60.4s3.

References

Wang F, Chen X, Liu J, Yang K, Zhang B, Chen Z . Short-term versus long-term administration of single prophylactic antibiotic in elective gastric tumor surgery. Hepatogastroenterology. 2012; 59(118):1784-8. DOI: 10.5754/hge11784. View

Haley R, Morgan W, Culver D, White J, Emori T, Mosser J . Update from the SENIC project. Hospital infection control: recent progress and opportunities under prospective payment. Am J Infect Control. 1985; 13(3):97-108. DOI: 10.1016/s0196-6553(85)80010-9. View

Righi E, Aggazzotti G, Ferrari E, Giovanardi C, Busani S, Rinaldi L . Trends in ventilator-associated pneumonia: impact of a ventilator care bundle in an Italian tertiary care hospital intensive care unit. Am J Infect Control. 2014; 42(12):1312-6. DOI: 10.1016/j.ajic.2014.08.009. View

Plowman R . The socioeconomic burden of hospital acquired infection. Euro Surveill. 2003; 5(4):49-50. DOI: 10.2807/esm.05.04.00004-en. View

Umscheid C, Mitchell M, Doshi J, Agarwal R, Williams K, Brennan P . Estimating the proportion of healthcare-associated infections that are reasonably preventable and the related mortality and costs. Infect Control Hosp Epidemiol. 2011; 32(2):101-14. DOI: 10.1086/657912. View

McDonald M, Grabsch E, Marshall C, Forbes A . Single- versus multiple-dose antimicrobial prophylaxis for major surgery: a systematic review. Aust N Z J Surg. 1998; 68(6):388-96. DOI: 10.1111/j.1445-2197.1998.tb04785.x. View

Humphreys H, Smyth E . Prevalence surveys of healthcare-associated infections: what do they tell us, if anything?. Clin Microbiol Infect. 2006; 12(1):2-4. DOI: 10.1111/j.1469-0691.2005.01273.x. View

Flodgren G, Conterno L, Mayhew A, Omar O, Pereira C, Shepperd S . Interventions to improve professional adherence to guidelines for prevention of device-related infections. Cochrane Database Syst Rev. 2013; (3):CD006559. DOI: 10.1002/14651858.CD006559.pub2. View

Wenisch J, Schmid D, Kuo H, Simons E, Allerberger F, Michl V . Hospital-acquired Clostridium difficile infection: determinants for severe disease. Eur J Clin Microbiol Infect Dis. 2012; 31(8):1923-30. DOI: 10.1007/s10096-011-1522-5. View

10.

Giske C, Monnet D, Cars O, Carmeli Y . Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2007; 52(3):813-21. PMC: 2258516. DOI: 10.1128/AAC.01169-07. View

11.

Collignon P . Clinical impact of antimicrobial resistance in humans. Rev Sci Tech. 2012; 31(1):211-20. DOI: 10.20506/rst.31.1.2111. View

12.

Spencer R . Prevalence studies in nosocomial infections. Eur J Clin Microbiol Infect Dis. 1992; 11(2):95-8. DOI: 10.1007/BF01967059. View

13.

Han J, Jeong O, Ryu S, Jung M, Park Y . Efficacy of single-dose antimicrobial prophylaxis for preventing surgical site infection in radical gastrectomy for gastric carcinoma. J Gastric Cancer. 2014; 14(3):156-63. PMC: 4199882. DOI: 10.5230/jgc.2014.14.3.156. View

14.

Harbarth S, Sax H, Gastmeier P . The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect. 2003; 54(4):258-66; quiz 321. DOI: 10.1016/s0195-6701(03)00150-6. View

15.

Bratzler D, Dellinger E, Olsen K, Perl T, Auwaerter P, Bolon M . Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health Syst Pharm. 2013; 70(3):195-283. DOI: 10.2146/ajhp120568. View

16.

Starzengruber P, Lusignani L, Wrba T, Mitteregger D, Indra A, Graninger W . Severe Clostridium difficile infection: incidence and risk factors at a tertiary care university hospital in Vienna, Austria. Wien Klin Wochenschr. 2014; 126(13-14):427-30. DOI: 10.1007/s00508-014-0549-x. View

17.

Zarb P, Goossens H . European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe. Drugs. 2011; 71(6):745-55. DOI: 10.2165/11591180-000000000-00000. View

18.

Meddings J, Rogers M, Krein S, Fakih M, Olmsted R, Saint S . Reducing unnecessary urinary catheter use and other strategies to prevent catheter-associated urinary tract infection: an integrative review. BMJ Qual Saf. 2013; 23(4):277-89. PMC: 3960353. DOI: 10.1136/bmjqs-2012-001774. View